P60 Long-term reduction of relapse rate and confirmed...

P60 Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis

Hauser, S.L., Hartung, H.P., Brochet, B., Montalban, X., Naismith, R.T., Wolinsky, J.S., Manfrini, M., Garas, M., Model, F., Hubeaux, S., Kappos, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
130
Language:
english
Journal:
Clinical Neurophysiology
DOI:
10.1016/j.clinph.2019.04.703
Date:
August, 2019
File:
PDF, 40 KB
english, 2019
Conversion to is in progress
Conversion to is failed